Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors. (2017)
Attributed to:
MICA: Immunotherapy for oral cancer prevention and treatment
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.immuni.2017.03.013
PubMed Identifier: 28410988
Publication URI: http://europepmc.org/abstract/MED/28410988
Type: Journal Article/Review
Volume: 46
Parent Publication: Immunity
Issue: 4
ISSN: 1074-7613